カリフォルニア州における白血病の臨床試験
カリフォルニア州内の拠点で、白血病に関する28件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 1, Duarte
- Quetzal Site 7, Los Angeles
- Quetzal Site 5, Stanford
被験者募集中第3相
18歳〜71歳 · 全性別 · 2026/09/23更新 · NCT07504458Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT06824168(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04996875Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, La Jolla
被験者募集中第3相
18歳〜18歳 · 全性別 · 2026/09/08更新 · NCT07509151Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
- Stanford University, Palo Alto
被験者募集中第1相
1歳〜25歳 · 全性別 · 2026/09/01更新 · NCT06408194Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
- Children s Hospital of Los Angeles, Los Angeles
被験者募集中観察研究健康なボランティア歓迎
5歳以上 · 全性別 · 2026/08/31更新 · NCT05237986Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
- Lucille Packard Children's Hospital of Stanford University, Palo Alto
被験者募集中第1相
18 Months – 39 Years · 全性別 · 2026/08/21更新 · NCT07573111Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of California, Fresno, Clovis
- University of California, San Diego, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT07007312Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Health - Bowyer Oncology Center, Los Angeles
- UC Irvine Health Chao Family Comprehensive Cancer Center, Orange
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT06001788Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital Orange County, Orange
- UCSF School of Medicine, San Francisco
被験者募集中第2相
7歳〜25歳 · 全性別 · 2026/08/19更新 · NCT05082519AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Research Site, Duarte
- Research Site, Los Angeles
- Research Site, Palo Alto
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/08/19更新 · NCT06137118AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
- Stanford University, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06340737Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- City of Hope, Duarte
- Valkyrie Clinical Trials, Los Angeles
被験者募集中第1/2相
13歳〜90歳 · 全性別 · 2026/08/06更新 · NCT06533579Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
- David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/17更新 · NCT06810778Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/14更新 · NCT06580002Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- UCLA Department of Medicine, Los Angeles
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07216443A Study of Revumenib and Mezigdomide in People With Leukemia
- City of Hope Cancer Center (Data collection only), Duarte
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/06/22更新 · NCT07356154A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site, Duarte
- Dren Investigational Site, Irvine
- Dren Investigational Site, Redwood City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/17更新 · NCT05475925Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- City of Hope Comprehensive Cancer Center, Duarte
- Kaiser Permanente-Oakland, Oakland
- Lucile Packard Children's Hospital Stanford University, Palo Alto
- 他1件
被験者募集中観察研究
全年齢 · 全性別 · 2026/05/18更新 · NCT01790152A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Keck School of Medicine of USC, Los Angeles
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/30更新 · NCT04256317The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- City of Hope, Duarte
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
- 他1件
被験者募集中第1/2相
12歳〜95歳 · 全性別 · 2026/04/15更新 · NCT04329728A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Moores UC San Diego Cancer Center, La Jolla
- USC / Norris Comprehensive Cancer Center, Los Angeles
- UCLA - Bowyer Oncology Center, Los Angeles
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/13更新 · NCT05735184cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
- City of Hope - Duarte, Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2025/10/31更新 · NCT06549790SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- 他3件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- San Francisco VA Medical Center, San Francisco, CA, San Francisco
被験者募集中第2相
18歳〜80歳 · 全性別 · 2025/10/14更新 · NCT06520098A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- City of Hope Medical Center, Duarte
- University of California Los Angeles, Los Angeles
- Stanford Cancer Center, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/24更新 · NCT06501196Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
- Children's Hospital Los Angeles, Los Angeles
被験者募集中健康なボランティア歓迎
3歳以上 · 全性別 · 2025/08/03更新 · NCT06360718ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。